A 24-YEARS-OLD MALE WITH GIGANTISM, GROWTH HORMONE DEFICIENCY, SUSPECTED CLIVUS CHORDOMA, PRIMARY HYPOTHYROIDISM, HYPOGONADISM AND PANCYTOPENIA

Wayan Agung Arsana, M I D Pramudianti

Abstract


Preeliminary : Pituitary gigantism is a condition caused by the excessive secretion of growth hormone (GH). Growth Hormone is also the most common pituitary hormone deficient in pituitary disease. Chordoma is a bone primary tumor that grows slowly and rarely found. Hypothyroidism is a pathological condition due to thyroid hormone deficiency. Symptoms of hypogonadism is non-specific including libido disorders, erectile dysfunction and decreased muscle mass and no hair growth in the head or body.

Case : A 24-year-old man came with a knee-jerk complaint. Physical examination obtained increased growth of statural and body parts as well as loss of body hair. Laboratory investigation revealed pancytopenia, increased prolactin; decreased GH, IGF-1 and testosterone; increased TSH, decreased FT3 and FT4. Head MRI demonstrated the presence of mass in the clivus.

Discussion : In this case, the patient presents with clinical gigantism. However, laboratory examination shows decreased GH and IGF-1 which may be due to the suppressive effect of mass on the clivus bone to the pituitary. The suspicion of hypothyroid found alone or due to mass in the clivus bone still requires further examination. Hypogonadism can result from supression on the pituitary. Pancytopenia can be caused by deficiency of GH or from hypothyroidism.

Conclusion : Gigantism may occurred with deficiency GH and IGF-1 due to suppressed pituitary caused by chordoma.


Keywords


Gigantism, clivus chordoma, primary hypothyroidism, hypogonadism, pancytopenia

References


Young WF. The Netter Collection of Medical Illustrations: The Endocrine System. 2nd ed. Philadelphia: Elsevier, p 21-22; 2011.

Holt IG, Hanley NA. Essential Endocrinology and Diabetes. 6th ed. West Sussex: Blackwell Publishing, p 65-98; 2012.

Melmed S. Endocrinology : Adult and pediatric. 7th ed. Philadelphia: Elsevier, p:209-226e7; 2016.

Hannah-Shmoni F, Trivellin G, Stratakis CA. Genetics of Gigantism and Acromegaly. Growth Horm IGF Res. 2016;30-31: 37–41. doi:10.1016/j.ghir.2016.08.002.

Rhee N, Jeong K, Yang EM, Kim CJ. Gigantism caused by growth hormone secreting pituitary adenoma. Ann Pediatr Endocrinol Metab. 2014;19:96-99. doi :10.6065/apem.2014.19.2.96.

Durmaz SA, Bahceci M, Tuzku A, Gokalp D, Guzel A, Ayag H. An acromegalic patient with low Insulin-Like Growth Factor-1 levels: it may not be found to be elevated during diagnosis of acromegaly each time. Turkısh Journal of Clinics and Laboratory. 2015;6:45-48

Ayuk J, Sheppard MC. Growth hormone and its disorders. Postgrad Med J. 2006;82:24–30. doi:10.1136/pgmj.2005.036087.

Stagi S, Scalini P, Farello G, Verrotti A. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art. Italian Journal of Pediatrics . 2017;43:81. doi:10.1186/s13052-017-0402-8.

Devesa J, Almenglo C, Devesa P. Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?. Clinical Medicine Insights: Endocrinology and Diabetes. 2016;9:47–7. doi:10.4137/CMed.s38201.

Cordido F, Arnes JAG, Aspiroz MM, Vela ET. Practical guidelines for diagnosis and treatment of acromegaly. Endocrinol Nutr. 2013;60(8):457.e1-457.e15.

Labidi M, Watanabe K, Bouazza S, Bresson D, Bernat AL, George B, Froelich S. Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management. J Neurosurg Sci. 2016;60(4):476-84.

Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13: e69–76.

Hirosawa RM, Santos ABA, Franca MM, Vebris VE, Castro AVB, Zanini MA, Nunes VS. Intrasellar chondroid chordoma: A case report. ISRN Endocrinology. 2011. doi:10.5402/2011/259392.

Falconer MA, Bailey IC, Duchen LW. Surgical treatment of chordoma and chondroma of the skull base. J Neurosurg. 1968;29(3):261-75. doi:10.3171/jns.1968.29.3.0261.

Fernandez-Miranda J C, Gardner PA, Snyderman CH, Devaney KO, Mendenhall WM, Suarez C, Rinaldo A, Ferlito A. Clival chordomas: A pathological, surgical, and radiotherapeutic review. Wiley Online Library. 2013;p 892-906. doi:10.1002/hed.23415.

Virdi G, McGraw I, MacDuff E, Periasamy K, Sharma H. An Atypical Presentation of Chordoma: Case Report and Review. Orthop Muscular Syst. 2017; 6(4). doi: 10.4172/2161-0533.1000247.

What, Where is the Clivus [cited 2016 Sept 10}. Available on http://clivustumor.blogspot.co.id/2013/03/what-where-is-clivus.html

Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390:1550-62. doi:10.1016/S0140-6736(17)30703-1.

Luca P, Brabant G, Dattani M, Bonomi M, Feldt-Rasmussen U, Fliers E, Gruters A, et al. 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J. 2018. doi: 10.1159/000491388.

Aw TC, Yap CY. Thyroid function tests: Proceedings of Singapore Healthcare. 2011; 20(2):132-137

Basaria S. Male hypogonadism. Lancet. 2014;383:1250-63. doi:10.1016/S0140-6736(13)61126-5.

Rosenquist KJ, Kaiser UB. Pituitary Disorders : Diagnosis and Management. 1st ed. West Sussex: Wiley Blackwell. 2013. Chapter 12, Hypopituitarism; p.120-129.

Dohle GR, Arver S, Bettocchi C, Jones TH, Kliesch S. EAU Guidelines on Male Hypogonadism. European Association of Urology. 2017.

Lang D, Mead JS, Sykes DB. Hormones and the bone marrow: panhypopituitarism and pancytopenia in a man with a pituitary adenoma. J Gen Intern Med. 2015;30(5):692–6. doi:10.1007/s11606-014-3161-x.

Koh JH, Lee YJ, Kang JH, Choi BK, Jeon YK, Kim SS, Kim BH, Kim IJ. Pancytopenia associated with hypopituitarism in an acromegaly patient: A case report and a review of the literature. Endocrinol Metab. 2012;27(4):308-313. doi:10.3803/EnM.2012.27.4.308.




DOI: http://dx.doi.org/10.24293/ijcpml.v26i2.1478

Refbacks

  • There are currently no refbacks.